胃恶性瘤的代谢重编程的进展,以重塑瘤免疫微环境
Na Wang1, Kai Wang2, Feixue Song1
1Department of Oncology, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Journal of cancer research and therapeutics
|March 16, 2026
概括
胃癌 (GC) 的代谢重编程影响瘤生长和免疫逃避. 了解这些代谢变化为GC免疫治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
背景情况:
- 代谢重编程对于瘤细胞的生长和生存至关重要.
- 瘤的代谢变化会影响瘤的微环境和免疫反应.
- 胃癌的代谢格局与免疫逃避和患者预后有关.
研究的目的:
- 探索胃癌中的代谢重编程机制.
- 分析代谢重编程对胃瘤免疫微环境的影响.
- 为胃癌提出新的代谢免疫治疗策略.
主要方法:
- 在胃癌中对代谢重编程的文献综述.
- 分析胃癌新陈代谢与瘤免疫微环境之间的相互作用.
- 确定潜在的治疗目标和策略.
主要成果:
- 代谢重编程显著影响胃癌的进展和免疫逃避.
- 特定的代谢途径与免疫细胞透和GC中的功能有关.
- 针对新陈代谢和免疫力的联合疗法非常有前途.
结论:
- 代谢重编程是胃癌的关键驱动因素,影响其与免疫系统的相互作用.
- 准代谢途径是增强胃癌免疫疗法的可行策略.
- 对代谢-免疫相互作用的进一步研究可以为GC患者改善临床结果.
相关概念视频
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment
3.0K
3.0K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
